BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11965235)

  • 1. Future of monoclonal antibodies in the treatment of hematologic malignancies.
    Reff ME; Hariharan K; Braslawsky G
    Cancer Control; 2002; 9(2):152-66. PubMed ID: 11965235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
    Mihăilă RG
    Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
    Demichelis-Gómez R; Pérez-Sámano D; Bourlon C
    Curr Oncol Rep; 2019 Feb; 21(2):17. PubMed ID: 30715609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of hematologic malignancies: the road to the future.
    Sotomayor EM; Loughran TP
    Cancer Control; 2002; 9(2):97-8. PubMed ID: 11965230
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune Modulation in Hematologic Malignancies.
    Dhodapkar MV; Dhodapkar KM
    Semin Oncol; 2015 Aug; 42(4):617-25. PubMed ID: 26320065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer monoclonal antibodies for hematological malignancies.
    Castillo J; Winer E; Quesenberry P
    Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immunotherapies for hematologic malignancies.
    Nelson MH; Paulos CM
    Immunol Rev; 2015 Jan; 263(1):90-105. PubMed ID: 25510273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies as therapeutics in human malignancies.
    Pandey M; Mahadevan D
    Future Oncol; 2014 Mar; 10(4):609-36. PubMed ID: 24754592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy for hematologic malignancies.
    Kuriakose P
    Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies.
    Tian Z; Liu M; Zhang Y; Wang X
    J Hematol Oncol; 2021 May; 14(1):75. PubMed ID: 33941237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispecific antibody based therapeutics: Strengths and challenges.
    Thakur A; Huang M; Lum LG
    Blood Rev; 2018 Jul; 32(4):339-347. PubMed ID: 29482895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era.
    Klener P; Etrych T; Klener P
    Curr Med Chem; 2019; 26(6):1002-1018. PubMed ID: 28990505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibody therapy for malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer vaccines for hematologic malignancies.
    Borrello IM; Sotomayor EM
    Cancer Control; 2002; 9(2):138-51. PubMed ID: 11965234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Immunotherapy: The Dawn of Antibody Cocktails.
    Marrocco I; Romaniello D; Yarden Y
    Methods Mol Biol; 2019; 1904():11-51. PubMed ID: 30539465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic monoclonal antibodies for hematological diseases].
    Harada T; Abe M
    Nihon Rinsho; 2014 Jun; 72(6):1143-8. PubMed ID: 25016818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.